Onesource And Orbicular Secure USFDA Tentative Approval
21 Apr 2026 //
EXPRESSPHARMA
SFDA Approves OneSource`s Generic Semaglutide in Saudi Arabia
11 Feb 2026 //
EXPRESSPHARMA
OneSource Specialty Pharma appoints Jeffrey Wong as CBO
08 Jul 2025 //
INDPHARMAPOST
OneSource Specialty Pharma`s Bangalore facility maintains US FDA
10 Jun 2025 //
#N/A
OneSource Specialty Pharma reports Q4 FY25 PAT of Rs. 98.50 Cr
06 May 2025 //
INDPHARMAPOST
OneSource pharma gets ANVISA GMP for Bengaluru unit 2
10 Apr 2025 //
EXPRESSPHARMA
NCLT Approval for creation OneSource India’s 1st Specialty CDMO
19 Nov 2024 //
MONEY CONTROL

Market Place
Sourcing Support